Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENYM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,600
Award facts
- Contract value 100% obligated
- $30,599.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,599.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 21, 2026, with an ultimate completion date of January 22, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy, which authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally.
Under this delivery order, DMS Pharmaceutical Group will supply pharmaceutical products and medical consumables to support federal military healthcare requirements. The company's established performance history across multiple therapeutic categories, including oncology treatments, immunosuppressants, specialty surgical products, vaccines, and routine pharmaceuticals, positions it as a critical supplier within the federal pharmaceutical supply chain. As one of multiple regional prime vendor contractors under the PPV-G GEN V program, DMS Pharmaceutical Group continues to demonstrate its capability to fulfill the diverse and specialized pharmaceutical requirements of military healthcare facilities worldwide through a contract structure extending through December 31, 2036.
Quick answers
Who was awarded contract SPE2DU26FENYM?
SPE2DU26FENYM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DU26FENYM worth?
The government has obligated $30,600 on SPE2DU26FENYM.
Is contract SPE2DU26FENYM an order under another contract?
Yes. SPE2DU26FENYM is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENYM competed?
The extent of competition for SPE2DU26FENYM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award